• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚砜基磷酰胺酯反义寡核苷酸作为一种替代硫代磷酸酯的选择,具有改善的生化和生物学性质。

Mesyl phosphoramidate antisense oligonucleotides as an alternative to phosphorothioates with improved biochemical and biological properties.

机构信息

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences (ICBFM SB RAS), 630090 Novosibirsk, Russia.

Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT 06520;

出版信息

Proc Natl Acad Sci U S A. 2019 Jan 22;116(4):1229-1234. doi: 10.1073/pnas.1813376116. Epub 2019 Jan 8.

DOI:10.1073/pnas.1813376116
PMID:30622178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6347720/
Abstract

Here we describe a DNA analog in which the mesyl (methanesulfonyl) phosphoramidate group is substituted for the natural phosphodiester group at each internucleotidic position. The oligomers show significant advantages over the often-used DNA phosphorothioates in RNA-binding affinity, nuclease stability, and specificity of their antisense action, which involves activation of cellular RNase H enzyme for hybridization-directed RNA cleavage. Biological activity of the oligonucleotide analog was demonstrated with respect to pro-oncogenic miR-21. A 22-nt anti-miR-21 mesyl phosphoramidate oligodeoxynucleotide specifically decreased the miR-21 level in melanoma B16 cells, induced apoptosis, reduced proliferation, and impeded migration of tumor cells, showing superiority over isosequential phosphorothioate oligodeoxynucleotide in the specificity of its biological effect. Lower overall toxicity compared with phosphorothioate and more efficient activation of RNase H are the key advantages of mesyl phosphoramidate oligonucleotides, which may represent a promising group of antisense therapeutic agents.

摘要

在这里,我们描述了一种 DNA 类似物,其中每个核苷酸位置的亚磺酰(甲烷磺酰基)磷酰胺取代了天然的磷酸二酯基团。与经常使用的 DNA 硫代磷酸酯相比,这些寡聚物在 RNA 结合亲和力、核酸酶稳定性和反义作用的特异性方面具有显著优势,反义作用涉及激活细胞内的 RNase H 酶进行杂交指导的 RNA 切割。寡核苷酸类似物的生物学活性已在致癌 miR-21 方面得到证明。22 个碱基对的抗 miR-21 亚磺酰磷酰胺寡脱氧核苷酸可特异性降低黑色素瘤 B16 细胞中的 miR-21 水平,诱导细胞凋亡,降低增殖并阻碍肿瘤细胞迁移,在其生物学效应的特异性方面优于等序硫代磷酸酯寡脱氧核苷酸。与硫代磷酸酯相比,总体毒性更低,并且更有效地激活 RNase H,是亚磺酰磷酰胺寡核苷酸的关键优势,它们可能代表一类有前途的反义治疗剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299a/6347720/cbfcf7eac535/pnas.1813376116fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299a/6347720/fafd48eab272/pnas.1813376116fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299a/6347720/7a5950706d8a/pnas.1813376116fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299a/6347720/cbfcf7eac535/pnas.1813376116fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299a/6347720/fafd48eab272/pnas.1813376116fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299a/6347720/7a5950706d8a/pnas.1813376116fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299a/6347720/cbfcf7eac535/pnas.1813376116fig03.jpg

相似文献

1
Mesyl phosphoramidate antisense oligonucleotides as an alternative to phosphorothioates with improved biochemical and biological properties.亚砜基磷酰胺酯反义寡核苷酸作为一种替代硫代磷酸酯的选择,具有改善的生化和生物学性质。
Proc Natl Acad Sci U S A. 2019 Jan 22;116(4):1229-1234. doi: 10.1073/pnas.1813376116. Epub 2019 Jan 8.
2
RNase H-independent antisense activity of oligonucleotide N3 '--> P5 ' phosphoramidates.寡核苷酸3'→5'磷酰胺酯的核糖核酸酶H非依赖性反义活性。
Nucleic Acids Res. 1997 Feb 15;25(4):776-80. doi: 10.1093/nar/25.4.776.
3
Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency.靶向 miR-21 的 Mesyl 膦酰胺酸骨架修饰反义寡核苷酸,具有增强的体内治疗效力。
Proc Natl Acad Sci U S A. 2020 Dec 22;117(51):32370-32379. doi: 10.1073/pnas.2016158117. Epub 2020 Dec 7.
4
Mesyl Phosphoramidate Oligonucleotides as Potential Splice-Switching Agents: Impact of Backbone Structure on Activity and Intracellular Localization.甲磺酸磷酰胺寡核苷酸作为潜在的剪接转换剂:主链结构对活性和细胞内定位的影响。
Nucleic Acid Ther. 2021 Jun;31(3):190-200. doi: 10.1089/nat.2020.0860. Epub 2021 May 14.
5
Structure-activity relationship study of mesyl and busyl phosphoramidate antisense oligonucleotides for unaided and PSMA-mediated uptake into prostate cancer cells.甲磺酸酯和丁磺酸酯磷酰胺酸酯反义寡核苷酸在无辅助及PSMA介导下进入前列腺癌细胞的构效关系研究
Front Chem. 2024 Mar 4;12:1342178. doi: 10.3389/fchem.2024.1342178. eCollection 2024.
6
Enzymatic and hybridization properties of oligonucleotide analogs containing novel phosphoramidate internucleotide linkages.含有新型磷酸酰胺酯核苷酸间连接的寡核苷酸类似物的酶促性质和杂交性质。
Nucleosides Nucleotides Nucleic Acids. 2004 May;23(5):777-87. doi: 10.1081/NCN-120039357.
7
Carba-LNA-5MeC/A/G/T modified oligos show nucleobase-specific modulation of 3'-exonuclease activity, thermodynamic stability, RNA selectivity, and RNase H elicitation: synthesis and biochemistry.Carba-LNA-5MeC/A/G/T 修饰的寡核苷酸表现出碱基特异性的 3'-外切酶活性、热力学稳定性、RNA 选择性和 RNase H 诱导的调节:合成与生物化学。
J Org Chem. 2011 Jun 3;76(11):4408-31. doi: 10.1021/jo200073q. Epub 2011 May 4.
8
Design of antisense oligonucleotides stabilized by locked nucleic acids.由锁核酸稳定的反义寡核苷酸的设计
Nucleic Acids Res. 2002 May 1;30(9):1911-8. doi: 10.1093/nar/30.9.1911.
9
Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids.大肠杆菌核糖核酸酶H1的结合亲和力和特异性:对反义寡核苷酸-RNA杂交体催化动力学的影响
Biochemistry. 1997 Jan 14;36(2):390-8. doi: 10.1021/bi962230p.
10
Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.硫代磷酸酯寡核苷酸是人类DNA聚合酶和核糖核酸酶H的抑制剂:对反义技术的影响。
Mol Pharmacol. 1992 Feb;41(2):223-9.

引用本文的文献

1
Chemical Modifications in Nucleic Acid Therapeutics.核酸疗法中的化学修饰
Methods Mol Biol. 2025;2965:57-126. doi: 10.1007/978-1-0716-4742-4_3.
2
Redesigning miR-34a: structural and chemical advances in the therapeutic development of an miRNA anti-cancer agent.重新设计miR-34a:miRNA抗癌药物治疗开发中的结构与化学进展
Biochem Soc Trans. 2025 Aug 4. doi: 10.1042/BST20253010.
3
Endogenous Ribonucleases: Therapeutic Targeting of the Transcriptome Through Oligonucleotide-Triggered RNA Inactivation.内源性核糖核酸酶:通过寡核苷酸触发的RNA失活对转录组进行治疗靶向

本文引用的文献

1
Peptide-oligonucleotide conjugates exhibiting pyrimidine-X cleavage specificity efficiently silence miRNA target acting synergistically with RNase H.具有嘧啶-X 切割特异性的肽-寡核苷酸缀合物与 RNase H 协同作用,有效沉默 miRNA 靶标。
Sci Rep. 2018 Oct 9;8(1):14990. doi: 10.1038/s41598-018-33331-z.
2
Alicaforsen, an Antisense Inhibitor of Intercellular Adhesion Molecule-1, in the Treatment for Left-Sided Ulcerative Colitis and Ulcerative Proctitis.阿利卡福森,一种细胞间黏附分子-1的反义抑制剂,用于治疗左侧溃疡性结肠炎和溃疡性直肠炎。
Dig Dis. 2018;36(2):123-129. doi: 10.1159/000484979. Epub 2017 Dec 5.
3
Nucleic acid binding proteins affect the subcellular distribution of phosphorothioate antisense oligonucleotides.
Biomolecules. 2025 Jul 4;15(7):965. doi: 10.3390/biom15070965.
4
RNA chemistry and therapeutics.RNA化学与治疗学。
Nat Rev Drug Discov. 2025 Jul 14. doi: 10.1038/s41573-025-01237-x.
5
Opening new frontiers with catalytic nucleic acids in miRNA inhibition.利用催化核酸在微小RNA抑制方面开拓新领域。
Front Pharmacol. 2025 Jun 23;16:1604711. doi: 10.3389/fphar.2025.1604711. eCollection 2025.
6
Solution-Phase Synthesis of Boranophosphate and Boranophosphate/Phosphorothioate/Phosphate Chimeric Oligonucleotides via the H-Boranophosphonate Method.通过氢硼膦酸酯法进行硼磷酸酯及硼磷酸酯/硫代磷酸酯/磷酸酯嵌合寡核苷酸的溶液相合成
J Org Chem. 2025 Jul 4;90(26):8966-8985. doi: 10.1021/acs.joc.5c00583. Epub 2025 Jun 20.
7
Lipid Nanovesicles in Cancer Treatment: Improving Targeting and Stability of Antisense Oligonucleotides.癌症治疗中的脂质纳米囊泡:提高反义寡核苷酸的靶向性和稳定性
Drug Des Devel Ther. 2025 Feb 14;19:1001-1023. doi: 10.2147/DDDT.S507402. eCollection 2025.
8
Cancer theragnostics: closing the loop for advanced personalized cancer treatment through the platform integration of therapeutics and diagnostics.癌症治疗诊断学:通过治疗与诊断的平台整合,为先进的个性化癌症治疗闭环。
Front Bioeng Biotechnol. 2025 Jan 17;12:1499474. doi: 10.3389/fbioe.2024.1499474. eCollection 2024.
9
Synthesis of New Polyfluoro Oligonucleotides via Staudinger Reaction.通过施陶丁格反应合成新型多氟寡核苷酸。
Int J Mol Sci. 2024 Dec 31;26(1):300. doi: 10.3390/ijms26010300.
10
Evolution of antisense oligonucleotides: navigating nucleic acid chemistry and delivery challenges.反义寡核苷酸的发展:应对核酸化学及递送挑战
Expert Opin Drug Discov. 2025 Jan;20(1):63-80. doi: 10.1080/17460441.2024.2440095. Epub 2024 Dec 17.
核酸结合蛋白影响硫代磷酸酯反义寡核苷酸的亚细胞分布。
Nucleic Acids Res. 2017 Oct 13;45(18):10649-10671. doi: 10.1093/nar/gkx709.
4
Alicaforsen for the treatment of inflammatory bowel disease.阿利卡福生用于治疗炎症性肠病。
Expert Opin Investig Drugs. 2017 Aug;26(8):991-997. doi: 10.1080/13543784.2017.1349753. Epub 2017 Jul 6.
5
RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus.RNase H1 依赖性反义寡核苷酸在细胞质和细胞核中均能有效地指导 RNA 切割。
Mol Ther. 2017 Sep 6;25(9):2075-2092. doi: 10.1016/j.ymthe.2017.06.002. Epub 2017 Jun 27.
6
FDA-Approved Oligonucleotide Therapies in 2017.2017年美国食品药品监督管理局批准的寡核苷酸疗法
Mol Ther. 2017 May 3;25(5):1069-1075. doi: 10.1016/j.ymthe.2017.03.023. Epub 2017 Mar 31.
7
FDA Approval of Nusinersen for Spinal Muscular Atrophy Makes 2016 the Year of Splice Modulating Oligonucleotides.美国食品药品监督管理局批准诺西那生用于治疗脊髓性肌萎缩症,使2016年成为剪接调节寡核苷酸之年。
Nucleic Acid Ther. 2017 Apr;27(2):67-69. doi: 10.1089/nat.2017.0665. Epub 2017 Feb 21.
8
Cellular uptake and trafficking of antisense oligonucleotides.反义寡核苷酸的细胞摄取和转运。
Nat Biotechnol. 2017 Mar;35(3):230-237. doi: 10.1038/nbt.3779. Epub 2017 Feb 27.
9
miRNases: Novel peptide-oligonucleotide bioconjugates that silence miR-21 in lymphosarcoma cells.miRNases:沉默 miR-21 的新型肽-寡核苷酸生物缀合物在淋巴肉瘤细胞中。
Biomaterials. 2017 Apr;122:163-178. doi: 10.1016/j.biomaterials.2017.01.018. Epub 2017 Jan 13.
10
MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer.微小RNA-21通过PTEN/PI3K/AKT信号通路促进食管癌细胞的增殖、迁移及抗凋亡能力。
Tumour Biol. 2016 Sep;37(9):12061-12070. doi: 10.1007/s13277-016-5074-2. Epub 2016 May 17.